Mammatech Announces Reverse Split, Company Developing Tactile Computer to Improve Clinical Breast Examination (CBE)
The Mammatech Corporation announced today a 20 to 1 reverse split in the company's shares of common stock effective 22 November 2002.
Gainesville, FL (PRWEB) November 12, 2004 -- The Mammatech Corporation
(MAMH.OB) announced today a 20 to 1 reverse split in the company's shares of
common stock effective 22 November 2002. The Company’s 8k stated that it intends
to seek financing for new product development. H.S. Pennypacker, Ph.D.,
President of Mammatech, said, "The company is developing a computer assisted
tactile trainer that will help produce and verify high levels of clinical breast
examination (CBE) skill.”
Dr. Mark K. Goldstein, Mammatech's Chairman,
reported that published studies continue to find that most breast cancers are
first detected by someone's hands. The Company’s MammaCare® program is a
recognized standard for proficient CBE.
* The MammaCare® program was
developed under grants from the National Cancer Institute.
* Barton, M.
B., Harris, R., & Fletcher, S. W. (1999). Does this patient have breast
cancer? The screening clinical breast examination: Should it be done? How?
Journal of the American Medical Association, 282(13), 1270-1280.
Contact
person:
Mark Goldstein, Ph.D.
(352) 375 0607
Company website www.mammacare.com
Email
address e-mail protected from spam bots
The company’s transfer agent is
Manhattan Transfer Registrar Company
57 Eastwood Road,
Miller Place,
NY 11764
# # #
Source : http://www.prweb.com/releases/2004/11/prweb178243.htm